5 Recruiting Rett Syndrome Phase 3 Clinical Trials
Active phase 3 studies for rett syndrome enrolling across the USA. Verify eligibility and contact site coordinators.
All Rett Syndrome studiesPhase 3 Studies for Rett Syndrome
🔵 Active, Not Recruiting Phase3
Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
📍 Ep0247 21010 — Little Rock, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase3
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
📍 Biomed Testing Facility # BIO-01-85012 — Phoenix, Arizona
View Study & Checklist ➔